Physician profile
Eric J Nelson
NPI 1609838705
$3,030.33
in general payments reported to CMS, 2019-2025
26 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $733 · 2020: $371 · 2021: $232 · 2022: $104 · 2023: $752 · 2024: $519 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,590.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $446.86 | 2019-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $422.58 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $416.18 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $222.36 | 2019-2024 | Xarelto |
| Intuitive Surgical, INC. | $174.90 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $163.05 | 2021-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $157.80 | 2023-2024 | Watchman Flx |
| Medtronic, INC. | $141.35 | 2023 | Micra |
| Abbott Laboratories | $135.86 | 2021-2025 | Jot Dx |
| Pfizer INC. | $113.36 | 2021-2024 | |
| Abiomed | $105.18 | 2024-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.24 | 2019-2023 | Jardiance |
| Medtronic Vascular, INC. | $86.83 | 2019-2020 | |
| Edwards Lifesciences Corporation | $54.41 | 2019-2022 | |
| Heartflow, INC. | $45.72 | 2023-2024 | Ffrct |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $43.84 | 2020 | |
| Merck Sharp & Dohme LLC | $37.63 | 2023-2024 | Verquvo, Bridion |
| Lundbeck LLC | $20.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.87 | 2021 | |
| Inspire Medical Systems, INC. | $19.76 | 2025 | Inspire |
| Lantheus Medical Imaging, INC. | $19.18 | 2023 | Definity |
| Astrazeneca Pharmaceuticals Lp | $18.23 | 2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $18.06 | 2023 | Arcalyst |
| Phadia US INC. | $16.83 | 2022 | |
| Cvrx, INC. | $16.28 | 2024 | Barostim Neo System |
| G Medical Diagnostic Services, INC. | $15.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.